Congen Pharma showcased at CPHI & PMEC Pharmaceutical Industry Exhibition, jointly building a new highland for the pharmaceutical industry in South China and Asia
Publish Time:
2024-09-12
The three-day CPHI & PMEC Pharmaceutical Industry Expo (Shenzhen) concluded successfully from September 9th to 11th! This year's exhibition brought together 400+ high-quality exhibitors and 10,000+ visitors from more than 40 countries and regions, once again presenting a grand industry event connecting the upstream and downstream of the pharmaceutical industry and global trade opportunities to the global pharmaceutical industry, showcasing the development achievements and unlimited potential of the South China pharmaceutical industry to the international market!
Congen Pharma brought the world's first EMPHASES ® new liquid-phase peptide synthesis technology and Semaglutide, Tirzepatide full industry chain products, attracting much attention. Domestic and foreign customers came in an endless stream on-site, constantly consulting, discussing cooperation opportunities, and looking forward to future development prospects.
Congen Pharma highlighted the world's first EMPHASES ® new liquid-phase peptide synthesis technology, which not only achieves green and efficient peptide chemical synthesis, but also breaks the limitations of traditional solid-phase synthesis methods, enabling large-scale peptide production and significantly reducing costs to 1/3. Through this technology, Congen Pharma provides more sustainable and affordable peptides for the pharmaceutical and cosmetic industries, meeting the urgent market demand for high-quality, low-cost peptide raw materials, and simultaneously providing the industry with competitive advantages in the synthesis process and quality research services for drug peptides such as Tirzepatide and Semaglutide.
The GLP-1 (Semaglutide, Tirzepatide) industry chain, with its quality and price advantages, including oral enhancers, long-acting side chains, and peptide fragments, has won the favor and attention of customers.
Gathering in Shenzhen, embracing the golden autumn, joining forces to build dreams and start a new chapter. Looking to the future, Congen Pharma will continue to strengthen and deepen regional cooperation, using innovative technologies and high-quality products to contribute to the high-quality development of the industry, jointly building a new highland for the pharmaceutical industry in South China and Asia, allowing sustainable and affordable peptides to benefit human beauty and health!
Relevant Information
